Literature DB >> 34211599

The incidence of avascular necrosis following a cohort of treated developmental dysplasia of the hip in a single tertiary centre.

Rahim Nawaz Hussain1, Darius Rad2, William John Watkins3, Clare Carpenter2.   

Abstract

PURPOSE: Avascular necrosis (AVN) may occur following treatment for developmental dysplasia of the hip (DDH). The primary aim of this study was to identify the incidence of AVN in a cohort of patients treated for DDH. Secondary aims were to classify AVN using available classification systems, analyze the correlation between the systems and investigate their relationship with the age at diagnosis of DDH.
METHODS: An 11-year retrospective study was carried out at a single tertiary centre, using data from the clinical portal (patient records database) and IMPAX (system used to store plain radiographic images). Clinical details (patient demographics and outcomes) and plain radiographic images were used to identify cases of DDH and categorize cases of AVN using available classification systems: Tonnis and Kuhlmann, Kalamchi and McEwen, Bucholz and Ogden and Salter. Severin was used to assess final clinical outcome.
RESULTS: In total, 405 (522 hips) cases of DDH were identified, of which 213 resolved without treatment, 93 were treated conservatively and 99 surgically. Only treated cases were included in the analysis (n = 192). AVN (45/99; 45.5%) was found to occur only postoperatively. A positive correlation was present between age at presentation and severity of AVN as classified according to Salter's criteria (chi-squared p value < 0.01).
CONCLUSION: AVN incidence was 23.4% (45/192) and only occurred in surgically treated patients. Older age at diagnosis was associated with a higher incidence of AVN, as defined according to Salter's criteria. The classification systems appeared to show no correlation amongst each other (p-value < 0.01). LEVEL OF EVIDENCE: III - Retrospective cohort study.
Copyright © 2021, The author(s).

Entities:  

Keywords:  Pavlik Harness; avascular necrosis; developmental dysplasia of the hip; paediatric orthopaedics

Year:  2021        PMID: 34211599      PMCID: PMC8223083          DOI: 10.1302/1863-2548.15.200246

Source DB:  PubMed          Journal:  J Child Orthop        ISSN: 1863-2521            Impact factor:   1.548


Introduction

True incidence of avascular necrosis (AVN) is variable within the literature. Previously, there has been an association reported between age at treatment of developmental dysplasia of the hip (DDH) and subsequent development of AVN,[1] with some studies suggesting an older age at treatment is more likely to lead to AVN, which may be because these patients tend to require more invasive treatment.[2,3] Historically, the rate of AVN has ranged between 4% and 60%, but a more recent systematic review concluded that 10% went on to develop significant AVN at mid-term postoperative follow-up.[4] Previous studies have been limited to small sample sizes and the use of differing classification systems. Pavlik harness has been reported as resulting in a low AVN rate in the literature, with some studies reporting no AVN in cases treated with Pavlik alone.[5,6] All the available classification systems were used in this study to classify the cases of AVN and severin criteria was used to assess the final clinical outcome.[10] Statistical correlation between these systems was also assessed. Salter’s criteria[7] can be used to diagnose AVN, although it is limited only to cases where ‘complete’ AVN has occurred. In cases where there is fragmentation or irregular ossification of the femoral head it may not be as useful.[1] In such cases, other classification systems are available, such as Bucholz and Ogden, Kalamchi and MacEwen, Tonnis and Kuhlmann and Severin.[8-10] Nonetheless, these have been criticized for having low levels of interobserver and intraobserver reliability and also a degree of ambiguity which makes it difficult to use in clinical situations.[8,9] Severin was used as it is regarded as one of the most reliable, with low inter observer variability.[10] This study aimed to qualify the incidence of AVN in a consecutive cohort of patients treated surgically and non-surgically for DDH over an 11-year period in a single tertiary centre.

Materials and methods

This was a retrospective cohort study which analyzed data collected between 1 February 2007 and 30 November 2017. The institution clinical portal was used to obtain clinical information (age at referral, sex, side affected, Graf type (where applicable), treatments received), clinical outcomes and complications for cases which were referred to a tertiary centre. Radiographic images were obtain using the IMPAX (Mortsel, Belgium; (DRAgfa picture archiving and communication system-proprietary software for use at medical facilities using a digital radiology imaging system) and analyzed by a post-Certification of Completion of Training Senior Paediatric Orthopaedic fellow (DR). Both databases were used to confirm the diagnosis of DDH, classify using the known systems and to analyze final clinical outcome using Severin. Cases of AVN were classified using the available classification systems and the proportions of AVN in each group were calculated. A large series of follow-up radiographs were available and thus correlation between the classification systems or between other parameters could be identified if present. This is consistent with Tsukagoshi et al[ who looked at correlation between Salter and Kalamchi. Subgroup analysis determined whether the rates of AVN were affected by the age of the individual at initial presentation, the severity of hip dysplasia (Graf grading (if applicable)) and treatment modality (i.e. Pavlik, closed versus open reduction (OR) versus pelvic osteotomy (PO)/femoral osteotomy (FO). Successful treatment was defined as one which did not lead to development of AVN, as this was the main aim of this study. Data was classified into three groups according to the age at initial presentation. Group 1 included individuals less than three months, as this is the period of highest remodelling potential of the acetabulum, as suggested by Graf’s Reifungskurve.[12] Group 2 included individuals aged three months up to, but not including, 18 months. Group 3 included individuals aged 18 months and older. This age (18 months and older) has been the historical age at presentation/treatment variable for DDH as it guided management options such as the decision to carry out closed versus open reduction or the addition of osteotomy procedures. For the purpose of establishing categories of age at presentation versus treatment modality we decided to continue using this age model. However, perhaps this will need to be redefined or looked at from a broader perspective.[13,14] Patients who presented at 12 weeks or less were classified as an early presentation; post-12 weeks patients were classified as late. This was similar to the criteria used by Senaran et al.[15] Infants below the age of six months were defined as having DDH according to the sonographic method described by Graf.[12] Infants above six months underwent a plain anteroposterior radiograph and evaluated as per Tonnis.[8] The presence of AVN was assessed by identifying radiographic images taken at six-monthly intervals after treatment. Severity was categorized using the Tonnis and Kuhlman, Kalamchi and McEwen, Bucholz and Ogden and Salter classification systems. The Severin classification system was used to grade the final clinical outcome of the cases. Age at diagnosis of DDH was defined as the date DDH was detected on ultrasound scan (where applicable) or plain radiograph. The subsequent age at diagnosis of AVN was obtained by calculating the age of the individual one year after their final procedure to allow classification according to Salter’s criteria. Non-surgical treatment was defined as treatment with more conservative measures (double nappies, ossur brace, pavlik harness). Surgical treatment was defined as closed or open reduction with or without additional procedures, where applicable.

Inclusion/exclusion criteria

Patients with a confirmed diagnosis of DDH by clinical examination in conjunction with either an ultrasound scan or plain radiographs (infants aged over six months) were included in the study. Patients with complete clinical data regarding their treatment, clinical outcomes and complications were included. Only individuals who underwent treatment (whether surgical or non-surgical) were included in the statistical analysis. We excluded patients with no diagnosis of DDH, or who had an associated neuromuscular disorder.

Statistical analysis

This was performed using the statistics package IBM SPSS (Armonk, NY, USA) Statistics for Windows, Version 20.0. Data was expressed as ordinal categorical variables. Cross tabulation with chi-squared analysis was performed to evaluate the risk factors for AVN. Non-parametric Spearman’s rho correlation tests were also used for subgroup analyses. The level of significance was set at p < 0.05. A p-value 0.05 < p <0.1 is regarded as near significant.

Results

In all, 1816 patients were initially screened for DDH, of which 1411 were discounted due to not meeting the inclusion criteria. A further 213 cases were excluded as they did not receive any intervention and self-resolved. In total, 192 patients (247 hips) were included in this study (158 female and 34 male). The number of patients in each group and the demographics of the cohort are summaried in Tables 1 and 2.
Table 1

Summary of groups 1, 2 and 3

Group 1Group 2Group 3
Patients1025436
Hips1466338
Side affected
 Left332721
 Right251814
 Bilateral4492
Male patients2365
Female patients794831
Mean age, wks (range)5 (2.9)28 (18.7)122 (17.8)
Median age, wks (range)5 (-1 to 11)18 (12 to 69)93 (73 to 354)
Table 2

Demographics of the cohort

Demographic
Patients (hips)192 (247)
Male:female1:4.6
Mean age,[*] wks (range)34 (54)
Median age,[*] wks (range)10.5
Age range, wks (corrected for gestation)-1 to 354
Side affected
 Left80
 Right57
 Bilateral55

corrected for gestation

Summary of groups 1, 2 and 3 Demographics of the cohort corrected for gestation

Group 1

A total of 102 cases were present in this group. They were treated with double nappies, ossur brace, Pavlik harness, closed or open reduction. Figure 1 shows a summary of the cases treated in this group.
Fig. 1

Summary of cases in group 1. Total patients (hips) = 102 (146) (CR, closed reduction; AVN, avascular necrosis; OR, open reduction).

Summary of cases in group 1. Total patients (hips) = 102 (146) (CR, closed reduction; AVN, avascular necrosis; OR, open reduction). Six AVN cases were identified in group 1, of which three had closed reduction and three open reduction.

Group 2

A total of 54 patients received treatment in this group. This included ossur brace, Pavlik harness, closed reduction, closed reduction with additional procedures, open reduction and open reduction with additional procedures. Additional procedures included: an adductor tenotomy in three children who underwent a closed reduction and a delayed pelvic and femoral osteotomy on the left side of one child whose right side resolved with closed reduction alone. Figure 2 diagrammatically summarizes the cases treated in group 2 along with the treatment modalities
Fig. 2

Summary of cases in group 2. Total patients (hips) = 54 (63) (CR, closed reduction; AVN, avascular necrosis; PO, pelvic osteotomy; FO, femoral osteotomy; OR, open reduction).

Summary of cases in group 2. Total patients (hips) = 54 (63) (CR, closed reduction; AVN, avascular necrosis; PO, pelvic osteotomy; FO, femoral osteotomy; OR, open reduction). Cases of AVN in group 2 and the treatments received by these cases are summarized in Table 3.
Table 3

Avascular necrosis cases in group 2

ProcedureNumber of cases
Closed reduction4
Closed reduction, pelvic and femoral osteotomy1
Open reduction4
Open reduction and pelvic osteotomy2
Open reduction, pelvic osteotomy and femoral osteotomy3
Avascular necrosis cases in group 2

Group 3

A total of 36 patients were identified. Figure 3 summarizes the treatments received by this group diagrammatically.
Fig. 3

Summary of cases in group 3. Total patients (hips) = 36 (38) (CR, closed reduction; AVN, avascular necrosis; OR, open reduction; PO, pelvic osteotomy; FO, femoral osteotomy).

Summary of cases in group 3. Total patients (hips) = 36 (38) (CR, closed reduction; AVN, avascular necrosis; OR, open reduction; PO, pelvic osteotomy; FO, femoral osteotomy). Cases of AVN and the treatments received by each individual are summarized in Table 4.
Table 4

Avascular necrosis cases in group 3

ProcedureNumber of cases
Closed reduction3
Closed reduction with adductor tenotomy2
Closed reduction with pelvic osteotomy1
Open reduction only4
Open reduction and pelvic osteotomy9
Open reduction with pelvic and femoral osteotomy5
Open reduction with pelvic, femoral and periacetabular osteotomies1
Avascular necrosis cases in group 3

Cases of AVN

All incidence of AVN occurred with cases treated under general anaesthesia (open or closed reduction +/- additional procedures). A total of 23.4% (45/192) patients developed AVN. Three cases were in infants diagnosed with bilateral DDH, but only the hip which was affected by AVN was included in the analysis. In total, 31 cases had AVN on the left hip and 14 on the right. Table 5 summarizes the cases of AVN into different age groups. The mean age at presentation of the DDH cases, later diagnosed with AVN, was 81 weeks (-1 to 354; sd 74.7).
Table 5

Age groups of avascular necrosis cases

Age at presentation, mthsNumber of patients
< 610
6 to 126
12 to 188
18 to 2410
24 to 365
36 to 481
> 485
Age groups of avascular necrosis cases Table 6 summarizes the number of cases of AVN in the different classification systems, including the Severin classification for final clinical outcome.
Table 6

Classifications of avascular necrosis

Grade
Classification systemNo grade12345
Salter04111317
Kalamchi and McEwen1178118
Bucholz and Ogden11710116
Tonnis and Kuhlmann21413016
Severin3241341
Classifications of avascular necrosis The supplementary material summarizes the treatment received by these individuals, the age at presentation and the length of follow-up. Of those who underwent a successful closed reduction 28% (14/50) had signs of AVN. This included individuals with a simultaneous adductor tenotomy (n = 2) and a delayed pelvic osteotomy (n = 1) and combined pelvic and femoral osteotomy (n = 1). The highest incidence of AVN was within the subgroup that underwent an open reduction (62%; n = 31/50). This group included individuals with an additional pelvic osteotomy (n = 11) or combined pelvic and femoral osteotomy (n = 9).

AVN severity: classification and correlation with Severin

A significant difference in age distributions was found across all Salter’s criteria (chi-squared p < 0.01), but no such correlation was noted in the other classification systems (Table 5). The classification systems appear to show a statistically significant correlation among one another: Kalamchi versus Bucholz and Ogden, Tonnis and Kuhlmann and Severin; Bucholz and Ogden versus Tonnis and Kuhlmann and Severin; Tonnis and Kuhlmann versus Severin; age at presentation versus index procedure (Table 7).
Table 7

Summary of treatments, age at diagnosis and avascular necrosis (AVN)

TreatmentAverage age at diagnosis of DDH, mthsAge at AVN diagnosis (1 yr after date of first procedure)
Closed reduction only3.824
Open reduction only4.425
Open reduction and pelvic osteotomy1145
Open reduction and femoral osteotomy945
Summary of treatments, age at diagnosis and avascular necrosis (AVN) Salter has a significant relationship with age at presentation (p < 0.01). Furthermore, Salter’s criteria suggested a near significant relationship with Severin’s (p < 0.1) We found no correlation between age at presentation and/or index procedure in any of the other classification systems. A summary of the treatments received by patients in each group, age at diagnosis and the average age at which AVN was diagnosed is summarized in Table 7.

Graf grading versus AVN (age less than six months)

Table 8 summarizes the cases of DDH that were classified according to Graf.
Table 8

Summary of cases with Graf grading

Graf 2aGraf 2bGraf 2cGraf DGraf 3Graf 4
Patients35112723125
Hips35153634134
Side affected
 Left931201210
 Right946196
 Bilateral17491109
Male cases1214043
Female cases23102322722
Mean gestational age, wks5.5127.57.57.28
Median gestational age, wks (range)4.6 (2 to 16)13 (4 to 27)5.7 (1 to 25)7.5 (2 to 13)5.9 (1 to 22)7.3 (-1 to 22)
Cases of AVN000019

AVN, avascular necrosis

Summary of cases with Graf grading AVN, avascular necrosis No cases of AVN were seen in type 2a, 2b, 2c and D hips. In all, 10/45 (22%) cases of AVN were identified in Graf type 3 (n = 1) and Graf type 4 (n = 9). The remaining cases presented after the age of six months and a Graf grading was not applied. Significant differences were observed across all the Graf types (chi-squared p < 0.001). The odds ratio for AVN comparing only Graf type 4 with 3 was 16.88 (1.96 to 145.34) and the Fisher’s exact test gave p < 0.003 demonstrating the statistically significant difference between the two.

Age versus AVN

A logistic regression was implemented to analyze the effect of age at initial treatment on development of AVN. The model correctly predicted 83.9% of the cases. The overall model was found to be highly statistically significant (p < 0.01), meaning that the higher the age at initial treatment, the more likely the patient will develop AVN.

Discussion

The data above reveals that surgically more invasive treatment and higher Graf grades at initial presentation are also more likely to result in AVN. It may also reflect a late or suboptimal treatment protocol. A few terminological clarifications at the beginning of this discussion are necessary, specifically the relationship between AVN and proximal femoral growth disturbance (PFGD) as used by Weinstein and Dolan.[16] The key question posed by their study (and others which use PFGD rather than AVN) concerns the aetiology of this disturbance seen at maturity, i.e. natural dysplasia progression or iatrogenic.[17] This study also suggests that the classification system most commonly used (Salter’s) is potentially questionable due to characteristics not necessarily suggestive of vascular insult but increased vascularity following open reduction.[16] In keeping with Weinstein and Dolan’s manuscript,[16] our findings using Severin’s criteria did indicate a need to base our outcome conclusions on final follow-up radiographs and not rely on early changes with the ossific nucleusNon-surgical treatment led to a more successful outcome in groups with younger patients (group 1: 75%, group 2: 29.6%, group 3: 0%). We found that the younger the patient, the more likely that non-surgical treatment would resolve the DDH. No individuals who underwent non-surgical (double nappies, Ossur brace or Pavlik harness) treatment developed AVN. No child treated with Pavlik harness subsequently developed AVN. The success of Pavlik harness in this respect, which has been widely reported in the literature,[2,3] was found to be 100%. The oldest child to undergo treatment with Pavlik only in this study was 27 weeks. Previously it has been reported in the literature that in children above four months of age, the effectiveness of Pavlik is likely to be reduced,[18] however, in our study we found that it was preserved for a longer period. According to our findings, Pavlik seems to be beneficial up to the age of six months. However, the authors acknowledge that further studies are required to truly assess the significance of this finding. Interestingly, the utilization of double nappies seemed to have resolved type 2a DDH in six cases within our cohort. Although these hips are well known to spontaneously resolve with no treatment, dysplasia may persist in 5% to 10% of cases.[ The literature is very limited on this treatment modality and the authors acknowledge that further studies should be carried out to determine its success rate. The proportion of cases with AVN within the subgroup that underwent closed reduction was 28% (14/50). This included the use of additional procedures such as adductor tenotomy and Salter osteotomy, which is comparable with the current literature.[20-22] Malvitz and Weinstein[ reported a higher rate of AVN in this group and, similar to this paper, we do not routinely employ preoperative traction within this unit, which may be a contributory factor. A prospective multicentre study found a 25% AVN rate, with older age and longer immobilization as predictors of further corrective surgery and development of AVN.[23] In our study, 25% of individuals who underwent closed reduction required further corrective surgery; this was more apparent as the age of the individual at initial presentation increased. An important point to note is that 6/14 of the above cases discussed were Severin I (n = 1) or Severin II (n = 5), which are not clinically relevant cases of AVN. A similar methodology was adopted by Terjesen and Halvorsen[22] in their study, whereby they Severin I or II was delineated as a satisfactory outcome. Therefore, the AVN rate in the group of individuals who underwent closed reduction with or without additional procedures is actually lower if the above is taken into account (12% versus 28%). Of the 11 individuals who underwent closed reduction with adductor tenotomy, two developed AVN (18%). Although this is higher than in Tennant et al,[24] who described closed reduction with simultaneous adductor and psoas release in children under two and had comparatively better results, with an AVN rate of 1.5%. In our study, these two cases were found to be Severin type II which deems them as clinically non-significant. Adductor tenotomy with closed reduction has been mentioned several times in the literature as one of the risk factors for AVN.[7,25,26] However, Schur et al[27] report no significant difference in development of AVN. Overall, the correlation between adductor tenotomy and development of AVN appears minimal, as the aetiology of AVN in the context of closed reduction is multifactorial, so it is likely that later presentation at surgery is more statistically significant in our study. Shin et al[28] compared the use of osteotomy versus no osteotomy in patients who underwent closed reduction. No significant difference was found in the outcome between the two groups. However, the authors do acknowledge that the use of acetabular index (AI) and centre edge angle (CEA) in DDH patients is reliable. In addition to this, the indication for osteotomy was not standardized in this study, therefore, reducing its relevance clinically when dealing with a patient with DDH. Nevertheless, AI and CEA at the age of three years are recommended as parameters predicting the success of this procedure. In our study, two patients required closed reduction with a subsequent osteotomy. They both developed AVN. This suggests that subsequent osteotomy is not beneficial, even though it is difficult to draw definitive conclusions based on such a small sample. In the case of open reduction, the standard surgical approach used in the unit was a modified Smith Peterson. The AVN incidence for open reduction alone was 40.7% (11/27), which is comparable with the literature, although there is considerable variation.[29-34] Overall it is in agreement with the conclusion by Kothari et al[35] that open reduction alone provides the lowest risk of AVN compared with open reduction with additional procedures (11/27; 40.7% versus 20/23; 87%). In this review the group that underwent open reduction alone was younger than the other groups which underwent an additional pelvic osteotomy and, therefore, age may again be the confounding factor. In our study, we found that a large proportion of individuals who underwent open reduction with additional osteotomies subsequently developed AVN (20/23; 87%). It is important to note that quite a significant proportion of the cases which underwent open reduction alone or open reduction with additional procedures were Severin type I or II (32%; 16/50). Therefore, the high incidence of AVN recorded may not be clinically significant due to the Severin classification. Kothari et al[35] recorded AVN as clinically relevant if it was Kalamchi & MacEwen or Bucholz and Ogden 2 or greater. In the group that underwent open reduction alone, four cases fulfilled these criteria, therefore, they are not clinically relevant. Seven patients would be considered to have clinically relevant AVN. In the group that underwent open reduction with additional osteotomies five cases fulfil this criteria, resulting in total clinically relevant AVN cases of 15. Therefore, according to Kothari’s methodology AVN incidence would be 44% (22/50). This is lower than the overall incidence of AVN in this group (open reduction alone or open reduction with additional osteotomies), which stands at 62% (31/50). Generally, individuals older than six months at initial presentation were at greater risk of developing AVN compared with younger individuals (RR = 16.3). The age of the individual at initial presentation is dependent on a variety of factors that have changed within the unit over the years with the appreciation of the neonatal infant physical examination and the introduction of a selective screening programme in 2016. However, this had no impact on the number of patients presenting late to our institution. Utilizing the Graf technique and grading is well established,[36] with studies demonstrating its superiority when compared with other ultrasonographic methods.[37-41] In this study, only Graf 3 or 4 hips developed AVN. These decentred hips by nature are more difficult to treat with a harness and required more intervention when compared with the lower Graf grades, hence increasing their risk of AVN. This study sought to classify AVN cases using all the available classification systems. It was not possible to identify the inter- and intraobserver variability of these classification methods, which is one of the shortfalls of this study. We reviewed the literature to identify studies which have previously analyzed the interobserver reliability of the known classification systems, but were only able to find Omeroglu et al’s[9] paper describing interobserver reliability in Kalamchi’s criteria. In addition to this, there is another study describing the poor reliability of Severin’s grades, calling into question the clinical conclusions of reports in which the Severin system has been used as the basis of proof.[10] Moreover, all the classification systems commonly used showed strong elements of correlation among one another, but not with age at presentation or index of surgical intervention. Tsukagoshi et al[11] pointed out that Salter’s criteria are predictive of outcome and correlated with the Kalamchi grade of AVN at ten years after DDH treatment. In our study we observed no such correlation. This is potentially due to our smaller sample size (45 versus 123). Nonetheless, we did identify another near significant correlation between Salter’s criteria and the severity of outcome through Severin’s classification at skeletal maturity. This does confirm the notion that a poorer Salter grade could correlate with a more severe final radiological outcome as per Severin’s classification. This statement is similar to the findings in Tsukagoshi et al,[11] however, no further correlation between Salter and other systems has been identified. Severin’s criteria were measured on the final follow-up radiograph. The range of follow-up in our cohort of patients with AVN was from two to 12 years. Other similar studies looking into the outcome of open reduction, closed reduction and pelvic osteotomy had similar follow-up time and criteria for grading Severin’s radiographic outcome.[42-44] Furthermore, we found that Severin’s classification at skeletal maturity has no correlation with the age at presentation. This finding was consistent with another study which found that the age at the time of closed reduction was not a risk factor for redislocation, AVN or poor radiographic outcomes according to the Severin grade.[36] There is a consensus in the literature that Severin grades I and II are not clinically relevant.[35] A total of 60% of our cases fit into this category. Therefore, the AVN which is clinically significant in this study (Severin grade III and IV), is actually 9.4% (18/192). Mean follow-up time for this cohort was 5.6 years, Range: 2-12 years The strengths of this study include that this was a consecutive cohort of patients treated within a single unit. The sample size gave it adequate power to detect a statistically significant difference. All infants were treated according to a departmental protocol for intervention amongst all treating clinicians. The limited sample used in this study is due to the fact that it was retrospective, thus relying on clear and consistent clinical records in order to collect the relevant data.

Conclusion

This study found the incidence of AVN in surgically treated late presentation DDH cases in a single tertiary centre to be comparable with the current literature. Salter’s criteria were the most useful in defining early AVN. Age at diagnosis was the consistent factor associated with AVN, which highlights the need for earlier detection with less invasive treatment methods in order to reduce its overall incidence. Although the incidence of AVN in our study is towards the higher end of the spectrum, this is likely to occur as a result of a single observer assessing the classifications. In addition, it may reflect the overall practice in our institution which may need to be evaluated to improve outcomes. One other important finding this study suggests is that perhaps we overclassify radiographs based on radiological changes found early after an intervention. We should certainly increase our follow-up time following any intervention and also incorporate patient-reported outcomes which are currently lacking in the paediatric population.
  42 in total

1.  The ferguson medial approach for open reduction of developmental dysplasia of the hip. A clinical and radiological review of 49 hips.

Authors:  N Kiely; U Younis; J B Day; T M Meadows
Journal:  J Bone Joint Surg Br       Date:  2004-04

2.  One-stage treatment of developmental dysplasia of the hip in untreated children from two to five years old. A comparative study.

Authors:  Cemil Ertürk; Mehmet Akif Altay; Raci Yarimpapuç; Ibrahim Koruk; U Erdem Işikan
Journal:  Acta Orthop Belg       Date:  2011-08       Impact factor: 0.500

3.  Comparing ultrasound measurements of neonatal hips using the methods of Graf and Terjesen.

Authors:  A Falliner; D Schwinzer; H-J Hahne; J Hedderich; J Hassenpflug
Journal:  J Bone Joint Surg Br       Date:  2006-01

4.  Effect of age on radiographic outcomes of patients aged 6-24 months with developmental dysplasia of the hip treated by closed reduction.

Authors:  YiQiang Li; XueMei Lin; YanHan Liu; JingChun Li; YuanZhong Liu; Bruno Pereira; Federico Canavese; HongWen Xu
Journal:  J Pediatr Orthop B       Date:  2020-09       Impact factor: 1.041

Review 5.  How Does Bony Surgery Affect Results of Anterior Open Reduction in Walking-age Children With Developmental Hip Dysplasia?

Authors:  Alpesh Kothari; George Grammatopoulos; Sally Hopewell; Tim Theologis
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

6.  Avascular necrosis of the femoral head as a complication of treatment for congenital dislocation of the hip in young children: a clinical and experimental investigation.

Authors:  R B Salter; J Kostuik; S Dallas
Journal:  Can J Surg       Date:  1969-01       Impact factor: 2.089

7.  Treatment of developmental dysplasia of the hip before walking: results of closed reduction and immobilization in hip spica cast.

Authors:  M Cemalettin Aksoy; Gürkan Ozkoç; Ahmet Alanay; Muharrem Yazici; Nasir Ozdemir; Adil Surat
Journal:  Turk J Pediatr       Date:  2002 Apr-Jun       Impact factor: 0.552

8.  Closed reduction and dynamic cast immobilization in patients with developmental dysplasia of the hip between 6 and 24 months of age.

Authors:  YiQiang Li; QingHe Zhou; Yuanzhong Liu; WeiDong Chen; JingChun Li; Federico Canavese; HongWen Xu
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-08-03

9.  Closed Vs. Open Reduction/Salter Innominate Osteotomy for Developmental Hip Dislocation After Age 18 Months: Comparative Survival at 45-Year Follow-up.

Authors:  Elizabeth J Scott; Lori A Dolan; Stuart L Weinstein
Journal:  J Bone Joint Surg Am       Date:  2020-08-05       Impact factor: 5.284

10.  Acetabular Remodeling and Role of Osteotomy After Closed Reduction of Developmental Dysplasia of the Hip.

Authors:  Chang Ho Shin; Won Joon Yoo; Moon Seok Park; Jun Ho Kim; In Ho Choi; Tae-Joon Cho
Journal:  J Bone Joint Surg Am       Date:  2016-06-01       Impact factor: 5.284

View more
  1 in total

Review 1.  Developmental Dysplasia of the Hip: Controversies in Management.

Authors:  Steven Garcia; Leah Demetri; Ana Starcevich; Andrew Gatto; Ishaan Swarup
Journal:  Curr Rev Musculoskelet Med       Date:  2022-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.